Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results
25 mars 2025 07h45 HE
|
Burning Rock Biotech Limited
Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results
Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer’s Disease
19 févr. 2025 08h30 HE
|
Neurogen Biomarking
CHICAGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Neurogen Biomarking, the world’s first ecosystem for memory and thinking concerns announced today that they have entered into an exclusive agreement to use...
Breast Cancer Liquid Biopsy Market to hit USD 1.9 billion by 2032, says Global Market Insights Inc.
06 janv. 2025 04h00 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Breast cancer liquid biopsy market size reached USD 305.9 million in 2023 and is projected to expand at a robust CAGR of 22.6% from 2024 to...
Burning Rock Announces Results of 2024 Annual General Meeting
31 déc. 2024 04h56 HE
|
Burning Rock Biotech Limited
Burning Rock Announces Results of 2024 Annual General Meeting
Burning Rock Reports Third Quarter 2024 Financial Results
03 déc. 2024 23h59 HE
|
Burning Rock Biotech Limited
Burning Rock Reports Third Quarter 2024 Financial Results
Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024
03 déc. 2024 06h45 HE
|
Burning Rock Biotech Limited
Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
05 nov. 2024 09h00 HE
|
PrognomiQ
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
10 oct. 2024 23h16 HE
|
Burning Rock Biotech Limited
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
Burning Rock Announces Changes to Management and Board of Directors
27 sept. 2024 08h37 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) (the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Reports Second Quarter 2024 Financial Results
22 août 2024 23h59 HE
|
Burning Rock Biotech Limited
Burning Rock Reports Second Quarter 2024 Financial Results